Bio-Rad StarBright Dyes for Flow Cytometry Offer Enhanced Resolution
Made up of Bio-Rad’s validated flow antibodies, the dyes offer maximal brightness and improved resolution of populations and low-density antigens for simple integration into multiplex panels.
StarBright Blue 700, StarBright Violet 440, and StarBright Violet 610 Dyes from Bio-Rad Laboratories are fluorescent nanoparticles designed for flow cytometry.
Made up of Bio-Rad’s validated flow antibodies, the dyes offer maximal brightness and improved resolution of populations and low-density antigens for simple integration into multiplex panels. Benefits of the dyes include:
- Resistance against photobleaching and stability with minimum lot-to-lot variation for consistent and reproducible staining
- Works with all common staining buffers, including special polymer dye staining buffers
- No loss of signal in fixation
- Narrow excitation and emission profiles for enhanced resolution in new and existing flow cytometry experiments.
“StarBright Dyes offer exceptional brightness with specific excitation and emission, allowing researchers to build brighter flow cytometry panels to enable better resolution of positive populations from background without the need for special buffers,” said Mike Blundell, Bio-Rad product manager, Life Science Group, in a Nov. 2, 2020 press release. “The unique profile of these dyes combined with Bio-Rad’s high-quality antibodies provides flexibility and offers a reliable alternative for incorporation into flow cytometry protocols.”
Source: Bio-Rad
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
